No Long-Term Effects of Antidepressant Use During Pregnancy
the Psychiatry Advisor take:
New studies indicate that there are no long-term behavioral impacts on children who are born to mothers that took antidepressants while pregnant. However, the same research indicated there may be an increased risk of postpartum hemorrhage.
Marte Handal, PhD, of the Norwegian Institute of Public Health, and colleagues examined the effects of prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) on motor skills development at age 3 in more than 51,000 children from the Norwegian Mother and Child Cohort Study. A total of 159 mothers reported long-term use of SSRIs during pregnancy.
While children of mothers who took SSRIs had slight delay in gross motor skills compared to other children, the difference was so small, it does not warrant clinical practice changes, the researchers reported in BJOG: An International Journal of Obstetrics and Gynaecology.
“Effective treatment of depression during pregnancy is essential and these results should not discourage healthcare professionals from prescribing or continuing antidepressant treatment to those who need it,” Handal said in a statement.
In another study, Australian researchers analyzed data from 49,000 women registered on the Danish National Birth Cohort to examine prenatal exposure to SSRIs on behavioral problems at age 7. Untreated prenatal depression was associated with an increased risk of problem behavior in the children, hyperactivity, inattention, and peer problems. But this increased risk was not seen in the children of mothers who took antidepressants.
However, researchers say there may be a link between antidepressants and postpartum hemorrhage.
The use of antidepressants during pregnancy has no long term neurodevelopmental or behavioral effects on the child, however they may be associated with an increased risk of postpartum hemorrhage, suggests the findings from three studies published in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).
The use of antidepressants such as selective serotonin reuptake inhibitors (SSRIs) to treat depression during pregnancy has become increasingly common, however, it is unclear whether any increased risk to the fetus, and health problems for the woman or baby, can be attributed directly to these drugs or may be caused by other factors. The research published today examines the effects SSRI use on the health of both the mother and the long term development of the child.
Psychiatry Advisor Articles
- Early Detection Markers of Alzheimer's Disease Possibly Identified
- Transcranial Direct Current Stimulation Inferior to Escitalopram
- Illicit Cannabis Use Among Adults Up Due to Medical Marijuana Laws
- Memory Training Opportunities Exist for Patients With Schizophrenia
- APA: Medical Discrimination Based on Size Psychologically, Physically Harms Patients
- Criteria For Identification of Smartphone Addiction
- Bipolar Disorder: Childhood Trauma Modulates Impact on Amygdala, Hippocampus
- Psychiatric Evaluations: Questions on Suicide Need to Be Rephrased
- Subsequent Suicide Attempts May Be Reduced by Emergency Department Interventions
- Elevated Levels of Childhood Adversity in Patients with Fibromyalgia and Chronic Widespread Pain
- Prescription Opioid Misuse Remains a Persistent Problem
- Revised Treatment Guidelines for Pediatric Acute Onset Neuropsychiatric Syndrome
- Long-term Response to Prophylactic Mood Stabilizers in Bipolar Disorder
- Medically Supervised Withdrawal, an Option for Pregnant Women Addicted to Opioids
- Navigating the Thin Line Between Identification & Intimacy With Patients